China NMPA Product Recall - Ventilator

On April 15, 2021, the National Medical Products Administration (NMPA) publicized a Class II voluntary recall initiated by Respironics California, Inc., and reported by Philips (China) Investment Co., Ltd. This action addresses a critical manufacturing issue identified with the spare batteries in specific models and batches of ventilators produced by Respironics California, Inc. The affected medical devices, including those registered under certificate number 20163545139, are subject to this corrective measure. This recall falls under the NMPA's regulatory framework for medical device oversight, aimed at ensuring product safety and quality in the market. Although no specific inspection dates are provided in this announcement, the recall signifies a manufacturer-driven response to a detected product defect. The immediate required action is the comprehensive voluntary recall of all implicated ventilators, with detailed information concerning the specific models, specifications, and batches made available in the 'Medical Device Recall Event Report Form'. This ensures the removal of potentially hazardous products from circulation, underscoring the company's commitment to patient safety and compliance with NMPA standards.